Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 46,547 | 54,128 | 6,196 | 6,016 | 21,232 |
| Cost of Goods | 17,158 | 13,875 | N/A | N/A | N/A |
| Gross Profit | 29,389 | 40,253 | 6,196 | 6,016 | 21,232 |
| Operating Expenses | 196,980 | 162,517 | 94,328 | -97,323 | 58,658 |
| Operating Income | -167,432 | -121,390 | -88,133 | 103,339 | -37,426 |
| Interest Expense | 2,511 | 7,555 | 508 | 5,912 | 5,090 |
| Other Income | 6,557 | 310 | 2,197 | 1,582 | 322 |
| Pre-tax Income | -163,386 | -128,635 | -86,444 | 99,009 | -42,193 |
| Income Tax | -1,399 | 1,084 | -770 | 6,934 | -836 |
| Net Income Continuous | -161,988 | -129,719 | -85,674 | 92,075 | -41,358 |
| Net Income | $-161,988 | $-129,719 | $-85,674 | $92,075 | $-41,358 |
| EPS Basic Total Ops | -3.78 | -3.38 | -2.53 | 3.00 | -1.48 |
| EPS Basic Continuous Ops | -3.78 | -3.38 | -2.53 | 3.00 | -1.48 |
| EPS Diluted Total Ops | -3.78 | -3.38 | -2.53 | 3.00 | -1.48 |
| EPS Diluted Continuous Ops | -3.78 | -3.38 | -2.53 | 3.00 | -1.48 |
| EPS Diluted Before Non-Recurring Items | -3.78 | -3.38 | -2.54 | 3.00 | -1.48 |
| EBITDA(a) | $-161,029 | $-121,390 | $-86,082 | $104,053 | $-36,703 |